Nanoparticle drug delivery shows promise for shielding the heart from doxorubicin
A new review in Cardio-Oncology outlines how nanoparticle drug delivery systems could reduce doxorubicin-induced cardiotoxicity while preserving antitumor efficacy.
Tag: PEGylated liposomal doxorubicin
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development